A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Open Access
- 26 July 2021
- journal article
- review article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 37 (1) , e2805
Abstract
Introduction: Kratom (Mitragyna speciosa) is a tropical plant traditionally used as an ethnomedicinal remedy for several conditions in South East Asia. Despite the increased interest in its therapeutical benefits in Western countries, little scientific evidence is available to support such claims, and existing data remain limited to kratom's chronic consumption.Objective: Our study aims to investigate (pre)clinical evidence on the efficacy of kratom as a therapeutic aid and its safety profile in humans.Methods: A systematic literature search using PubMed and the Medline database was conducted between April and November 2020.Results: Both preclinical (N = 57) and clinical (N = 18) studies emerged from our search. Preclinical data indicated a therapeutic value in terms of acute/chronic pain (N = 23), morphine/ethanol withdrawal, and dependence (N = 14), among other medical conditions (N = 26). Clinical data included interventional studies (N = 2) reporting reduced pain sensitivity, and observational studies (N = 9) describing the association between kratom's chronic (daily/frequent) use and safety issues, in terms of health consequences (e.g., learning impairment, high cholesterol level, dependence/withdrawal).Conclusions: Although the initial (pre)clinical evidence on kratom's therapeutic potential and its safety profile in humans is encouraging, further validation in large, controlled clinical trials is required.Keywords
This publication has 117 references indexed in Scilit:
- The Combination of Mitragynine and Morphine Prevents the Development of Morphine Tolerance in MiceMolecules, 2013
- Inhibitory effect of mitragynine on human cytochrome P450 enzyme activitiesPharmacognosy Research, 2013
- Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa through Activation of Opioid Receptor SystemInternational Journal of Molecular Sciences, 2012
- Mitragynine Attenuates Withdrawal Syndrome in Morphine-Withdrawn ZebrafishPLOS ONE, 2011
- Evaluation of the Effects of Mitragyna speciosa Alkaloid Extract on Cytochrome P450 Enzymes Using a High Throughput AssayMolecules, 2011
- The evaluation of antinociceptive activity of alkaloid, methanolic, and aqueous extracts of Malaysian Mitragyna speciosa Korth leaves in ratsPharmacognosy Research, 2010
- Evaluation of Antioxidant and Antibacterial Activities of Aqueous, Methanolic and Alkaloid Extracts from Mitragyna Speciosa (Rubiaceae Family) LeavesMolecules, 2009
- Self‐treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)Addiction, 2008
- Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosaLife Sciences, 2004
- Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-admintstered mitragynine in miceLife Sciences, 1998